Blackford Platform is purpose-built for seamless integration with current systems. It
simplifies
management of multiple AI applications and algorithms, reduces system load, and ensures 24/7
performance monitoring via Blackford Dashboard™.
Our Strategic Partnerships include providers of medical imaging platforms, clinical workflow
solutions, pharma, cloud services and medical imaging equipment.
Here’s the latest instalment in our news updates from Blackford Platform Partners. Imaging AI specialist icometrix highlighted the publication of a recent
Blackford Analysis
Here’s the latest instalment in our news updates from Blackford Platform Partners.
Imaging AI specialist
icometrix highlighted the
publication of a recent study of commercially available AI software products, which showed that only 36 out of 100 products have peer-reviewed evidence supporting them. The company has also teamed up with Stanford University to identify differences in structural biomarkers and imaging predictors of global cognitive severity. In addition, icometrix announced the launch of
ALZimaging, an independent educational platform on current and future paradigms of neuroimaging in the management of Alzheimer's Disease. AI-powered breast health solution provider
Densitas announced the deployment of its intelliMammo A.I. platform across Canada’s Maritime Provinces. The company also announced it is sponsoring a
free webinar with Mammography Educators later this month. Neurovascular emergency AI specialist
Avicenna.AI announced the
publication of a new clinical study validating the use of its CINA software as a deep learning tool in the detection of intracranial hemorrhage and large vessel occlusion. Visualization and analytical solutions developer
Imaging Biometrics announced that it is sponsoring a Phase 1 clinical trial using an orally bioavailable agent to treat glioblastoma (GBM). The company is providing its IB Clinic brain tumour assessment software to help measure tumour progression. In addition, Imaging Biometrics announced that one of its customers, Dr Mark Shiroishi, will be delivering a
video lecture on Perfusion MRI of Brain Tumors later this month. Medical diagnostic provider
MaxQ AI secured registration from the UAE’s Ministry of Health and Prevention for Accipio Ix, Accipio Ax, and Accipio Dxg. Lung analysis firm
VIDA released its
texture analysis feature, which provides quantitative measures and distribution of ground glass/reticulation, consolidation and honeycombing. The company also hosted a
webinar interview with pulmonologist and author Michael J. Stephen, MD.
Stay tuned for more partner news next month!
